These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34282777)

  • 41. BRAF(V600E) mutation is highly prevalent in thyroid carcinomas in the young population in Fukushima: a different oncogenic profile from Chernobyl.
    Mitsutake N; Fukushima T; Matsuse M; Rogounovitch T; Saenko V; Uchino S; Ito M; Suzuki K; Suzuki S; Yamashita S
    Sci Rep; 2015 Nov; 5():16976. PubMed ID: 26584635
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pooled Analysis of RET/PTC Gene Rearrangement Rate in Sporadic and Radiogenic Thyroid Papillary Carcinoma].
    Ushenkova LN; Koterov AN; Biryukov AP
    Radiats Biol Radioecol; 2015; 55(4):355-88. PubMed ID: 26601537
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between genetic alterations and clinicopathological characteristics of papillary thyroid carcinoma.
    Kure S; Wada R; Naito Z
    Med Mol Morphol; 2019 Dec; 52(4):181-186. PubMed ID: 30788603
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics.
    Leeman-Neill RJ; Brenner AV; Little MP; Bogdanova TI; Hatch M; Zurnadzy LY; Mabuchi K; Tronko MD; Nikiforov YE
    Cancer; 2013 May; 119(10):1792-9. PubMed ID: 23436219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gene rearrangements in radiation-induced thyroid carcinogenesis.
    Rabes HM
    Med Pediatr Oncol; 2001 May; 36(5):574-82. PubMed ID: 11340615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic alterations in thyroid tumors from patients irradiated in childhood for tinea capitis treatment.
    Boaventura P; Pereira D; Celestino R; Mendes A; Nakasawa T; Teixeira-Gomes J; Sobrinho-Simões M; Soares P
    Eur J Endocrinol; 2013 Nov; 169(5):673-9. PubMed ID: 23966419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot.
    Musholt PB; Musholt TJ; Morgenstern SC; Worm K; Sheu SY; Schmid KW
    World J Surg; 2008 May; 32(5):722-8. PubMed ID: 18235983
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigation of V600E BRAF mutation in papillary thyroid carcinoma in the Polish population.
    Brzeziańska E; Pastuszak-Lewandoska D; Wojciechowska K; Migdalska-Sek M; Cyniak-Magierska A; Nawrot E; Lewiński A
    Neuro Endocrinol Lett; 2007 Aug; 28(4):351-9. PubMed ID: 17693984
    [TBL] [Abstract][Full Text] [Related]  

  • 49. BRAF(V600E) Mutation, RET/PTC1 and PAX8-PPAR Gamma Rearrangements in Follicular Epithelium Derived Thyroid Lesions - Institutional Experience and Literature Review.
    Şahpaz A; Önal B; Yeşilyurt A; Han Ü; Delibaşı T
    Balkan Med J; 2015 Apr; 32(2):156-66. PubMed ID: 26167339
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular genetic study comparing follicular variant versus classic papillary thyroid carcinomas: association of N-ras mutation in codon 61 with follicular variant.
    Di Cristofaro J; Marcy M; Vasko V; Sebag F; Fakhry N; Wynford-Thomas D; De Micco C
    Hum Pathol; 2006 Jul; 37(7):824-30. PubMed ID: 16784981
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic alterations of differentiated thyroid carcinoma in iodine-rich and iodine-deficient countries.
    Vuong HG; Kondo T; Oishi N; Nakazawa T; Mochizuki K; Inoue T; Tahara I; Kasai K; Hirokawa M; Tran TM; Katoh R
    Cancer Med; 2016 Aug; 5(8):1883-9. PubMed ID: 27264674
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinicopathological features of NTRK3 gene rearrangement papillary thyroid carcinoma].
    Li HQ; Chen XY; Yu XB; Chen LY; Zhang X; Jin L; Wu ZZ; Chen Z
    Zhonghua Bing Li Xue Za Zhi; 2022 Feb; 51(2):126-131. PubMed ID: 35152631
    [No Abstract]   [Full Text] [Related]  

  • 53. Mechanisms of mutagenesis in mammalian cells. Application to human thyroid tumours.
    Sarasin A; Bounacer A; Lepage F; Schlumberger M; Suarez HG
    C R Acad Sci III; 1999; 322(2-3):143-9. PubMed ID: 10196666
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The
    Zurnadzhy L; Bogdanova T; Rogounovitch TI; Ito M; Tronko M; Yamashita S; Mitsutake N; Chernyshov S; Masiuk S; Saenko VA
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885148
    [TBL] [Abstract][Full Text] [Related]  

  • 55. RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma.
    Romei C; Elisei R
    Front Endocrinol (Lausanne); 2012; 3():54. PubMed ID: 22654872
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of RET rearrangements in papillary thyroid carcinoma using RT-PCR and FISH techniques - A molecular and clinical analysis.
    Musholt TJ; Staubitz JI; Antonio Cámara RJ; Musholt PB; Humberg D; Springer E; Schad A
    Eur J Surg Oncol; 2019 Jun; 45(6):1018-1024. PubMed ID: 30472213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential responses of human papillary thyroid cancer cell lines carrying the RET/PTC1 rearrangement or a BRAF mutation to MEK1/2 inhibitors.
    Henderson YC; Fredrick MJ; Clayman GL
    Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):810-5. PubMed ID: 17709622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation.
    Bounacer A; Wicker R; Caillou B; Cailleux AF; Sarasin A; Schlumberger M; Suárez HG
    Oncogene; 1997 Sep; 15(11):1263-73. PubMed ID: 9315093
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of RET/PTC1 and RET/PTC3 gene rearrangements in Chennai population and its correlation with clinical parameters.
    Rao PJ; Vardhini NV; Parvathi MV; Murthy PB; Sudhakar G
    Tumour Biol; 2014 Oct; 35(10):9539-48. PubMed ID: 24957039
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma.
    He H; Li W; Yan P; Bundschuh R; Killian JA; Labanowska J; Brock P; Shen R; Heerema NA; de la Chapelle A
    Thyroid; 2018 Jun; 28(6):748-754. PubMed ID: 29768105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.